G Medical Innovations Lt... (GMVDW)
G Medical Innovations Ltd Statistics
Share Statistics
G Medical Innovations Ltd has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. G Medical Innovations Ltd's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for G Medical Innovations Ltd.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of -0.28.
| Current Ratio | 0.22 |
| Quick Ratio | 0.19 |
| Debt / Equity | -0.28 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.1 |
| Interest Coverage | 1.91 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0.92 |
| Inventory Turnover | 12.45 |
Taxes
| Income Tax | 16K |
| Effective Tax Rate | -0.11% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0, so G Medical Innovations Ltd's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 4.91 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 70.5 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, G Medical Innovations Ltd had revenue of 4.42M and earned -13.96M in profits. Earnings per share was 0.
| Revenue | 4.42M |
| Gross Profit | 784K |
| Operating Income | -27.41M |
| Net Income | -13.96M |
| EBITDA | -37.75M |
| EBIT | -30.21M |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 295K in cash and 2.09M in debt, giving a net cash position of -1.8M.
| Cash & Cash Equivalents | 295K |
| Total Debt | 2.09M |
| Net Cash | -1.8M |
| Retained Earnings | -115.26M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -18.48M and capital expenditures -2.12M, giving a free cash flow of -20.6M.
| Operating Cash Flow | -18.48M |
| Capital Expenditures | -2.12M |
| Free Cash Flow | -20.6M |
| FCF Per Share | 0 |
Margins
Gross margin is 17.74%, with operating and profit margins of -620.14% and -315.79%.
| Gross Margin | 17.74% |
| Operating Margin | -620.14% |
| Pretax Margin | -315.43% |
| Profit Margin | -315.79% |
| EBITDA Margin | -854.1% |
| EBIT Margin | -620.14% |
| FCF Margin | -466.06% |
Dividends & Yields
GMVDW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for GMVDW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 21, 2022. It was a backward split with a ratio of 1:35.
| Last Split Date | Nov 21, 2022 |
| Split Type | backward |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |